Researchers Optimistic about Genomics Funding, Rate Illumina and Life Tech Best in Class | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Despite a gray forecast for National Institutes of Health funding, researchers have a relatively positive outlook on genomics funding, a recent survey conducted jointly by GenomeWeb and investment firm Mizuho Securities has found.

Respondents to the survey also ranked Illumina, Life Technologies, and Roche as the companies with the best products in genomics research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."